Inventor · disambiguated record
Ming Gu
Also filed as: GU MING · GU MING CHENG
5 granted patents·12 pending applications·35 citations·filing 1997–2024
72Inventor score
Files withENLITISA SHANGHAI PHARMACEUTICAL CO LTD11JIANGYIN USUN PHARMACEUTICAL CO LTD3MERCK & CO INC2SHENZHEN INST ADV TECH1
Top patents by PatentIndex Score
17 records- 0178US2025302818A1Topical formulations comprising montelukast and combinations with mussel adhesive proteinsENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0273US11672792B2Topical formulations comprising montelukast and combinations with mussel adhesive proteinsENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Jun 13, 2023·1 cites·19 claims
- 0373US2023404992A1Topical formulations comprising montelukast and combinations with mussel adhesive proteinsENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0472US2025041377A1Pharmaceutical useENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0569US6001816AGene therapy for leptin deficiencyMERCK & CO INC·Filed 1997·Granted Dec 14, 1999·34 cites·3 claims
- 0669US2024218016A1Peptides and their use in the treatment of inflammationSHENZHEN INST ADV TECH·Filed 2020·Application pending·0 cites
- 0769US2023348536A1Conjugates of montelukast and peptidesENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0867US2023113836A1New conjugates of peptides and polysaccharideENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 0966US12129313B2Anti-inflammatory use of peptideENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2021·Granted Oct 29, 2024·0 cites·14 claims
- 1064US11680082B2Conjugates of montelukast and peptidesENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Jun 20, 2023·0 cites·40 claims
- 1155US2025066417A9New peptide-based diagnostic and therapeutic agentsENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1254US2021196783A1New pharmaceutical useJIANGYIN USUN PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 1351US2023331792A1New multi-functional oligopeptidesENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 1450US2024124521A1New peptidesENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 1549US11059859B2Anti-inflammatory use of peptideJIANGYIN USUN PHARMACEUTICAL CO LTD·Filed 2018·Granted Jul 13, 2021·0 cites·8 claims
- 1647US2024165247A1New peptide conjugatesJIANGYIN USUN PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1745US2003215423A1Gene therapy for obesityMERCK & CO INC·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ming Gu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →